Loading...

Asymchem Laboratories (Tianjin) Co., Ltd.

6821.HKHKSE
HealthcareBiotechnology
HK$71.40
HK$0.70(0.99%)

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) Company Profile & Overview

Explore Asymchem Laboratories (Tianjin) Co., Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) Company Profile & Overview

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.

SectorHealthcare
IndustryBiotechnology
CEODr. Hao Hong Ph.D.

Contact Information

No. 6 Dongting 3rd Street, Tianjin

Company Facts

9,595 Employees
IPO DateDec 10, 2021
CountryCN
Actively Trading

Frequently Asked Questions